Clinical Trial Update: The Establishment of a Registry and a Biorepository of Patients With Suspected Amniotic Fluid Embolism (AFE)

View source ↗

Summary

This clinical trial is establishing a registry and biorepository for patients with suspected amniotic fluid embolism to support future research.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amniotic Fluid Embolism

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Amniotic Fluid Embolism | Status: RECRUITING